via University of Cambridge
Researchers trying to turn off a gene that allows cancers to spread have made a surprising U-turn. By making the gene overactive and functional in the hearts of mice, they have triggered heart cell regeneration.
The inability of the heart to regenerate itself is a significant unmet clinical need
Since adult hearts cannot usually repair themselves once damaged, harnessing the power of this gene represents major progress towards the first curative treatment for heart disease.
“This is really exciting because scientists have been trying to make heart cells proliferate for a long time. None of the current heart disease treatments are able to reverse degeneration of the heart tissue – they only slow progression of the disease. Now we’ve found a way to do it in a mouse model,” said Dr Catherine Wilson, a researcher in the University of Cambridge’s Department of Pharmacology, who led the study.
The cell cycle – through which cells make copies of themselves – is tightly controlled in mammalian cells. Cancer develops when cells start to replicate themselves uncontrollably, and the Myc gene plays a key role in the process. Myc is known to be overactive in the vast majority of cancers, so targeting this gene is one of the highest priorities in cancer research. Much recent research has focused on trying to take control of Myc as a means of cancer therapy.
When the researchers made Myc overactive in a mouse model, they saw its cancerous effects in organs including the liver and lungs: huge amount of cells started replicating over the course of a few days. But in the heart, nothing much happened.
They found that Myc-driven activity in heart muscle cells is critically dependent on the level of another protein called Cyclin T1, made by a gene called Ccnt1, within the cells. When the Ccnt1 and Myc genes are expressed together, the heart switches into a regenerative state and its cells start to replicate. The results are published today in the journal Nature Communications.
“When these two genes were overexpressed together in the heart muscle cells of adult mice we saw extensive cell replication, leading to a large increase in the number of heart muscle cells,” said Wilson.
Heart failure affects around 23 million people worldwide each year, and there is currently no cure. After a heart attack, an adult human heart can lose up to one billion heart muscle cells – called cardiomyocytes. Unlike many other organs in the body, the adult heart can’t regenerate itself, so these cells are never replaced. Their loss reduces the strength of the heart and causes scar formation, heart failure and ultimately death.
Using a next generation sequencing technology called ChIP, the researchers were able to watch the action of Myc in the heart cells. Myc produces a protein – called a transcription factor – that binds to the DNA in specific cells and activates gene expression. But despite the protein binding successfully, the heart cells didn’t start to replicate themselves because the protein could not activate gene expression. Another protein vital to gene expression, Cyclin T1, was deficient in the heart. Adding it to the cells with the overactive Myc caused the cells to start proliferating.
“None of the current treatment options can reverse the degeneration of heart tissue. The inability of the heart to regenerate itself is a significant unmet clinical need,” said Wilson. “We found that even when Myc is switched on in a heart, the other tools aren’t there to make it work, which may be one of the reasons heart cancer is so extremely rare. Now we know what’s missing, we can add it and make the cells replicate.”
As the world’s population grows and the prevalence of heart failure increases, the cost of patient care is anticipated to increase dramatically. The researchers hope to develop their finding into a genetic therapy for the treatment of heart disease. “We want to use short-term, switchable technologies to turn on Myc and Cyclin T1 in the heart. That way we won’t leave any genetic footprint that might inadvertently lead to cancer formation,” said Wilson.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Heart cell regeneration
- Insight into merits and limitations of direct reprogramming strategies for cardiac regenerationon June 22, 2020 at 4:13 pm
Today, only a handful of cell therapy-based strategies that include induced pluripotent stem cells, embryonic stem cells, bone marrow, liposuction, heart biopsies are known ... hold a promising role ...
- Why do we never hear about heart cancer?on June 18, 2020 at 3:12 am
This is why. Heart cancer exists but it's extremely rare. The fact that heart muscle cells are difficult to regrow and regenerate is a reason why malignant tumours of the heart are rare. Even when a ...
- This study shows the first curative treatment for heart diseaseon June 17, 2020 at 3:20 am
A recent study from the University of Cambridge found that by making a gene that allows cancers to spread to be overactive and functional in the heart, they have triggered heart cell regeneration.
- Coronavirus: inside the UAE stem cell centre working to treat Covid-19on June 16, 2020 at 3:01 am
When Dr Yendry Ventura began work to set up the Abu Dhabi Stem Cell Centre in late 2018, there was, he says, nothing else "related to stem cell therapy” in the emirate. Fast forward to today and the ...
- New study investigates the impact of COVID-19 on sleepon June 15, 2020 at 3:59 am
An international group of researchers led by Professor Colin Espie from the Nuffield Department of Clinical Neurosciences at the University of Oxford is investigating the impact of the COVID-19 ...
Go deeper with Google Headlines on:
Heart cell regeneration
Go deeper with Bing News on:
Curative treatment for heart disease
- Will Scotland's coronavirus cure prove worse than the disease? – Murdo Fraser MSPon June 23, 2020 at 8:47 am
Given the economic crisis, problems in our schools, and 1,200 excess deaths unrelated to Covid-19, is the Scottish Government failing to ‘balance the harms’ effectively, writes Murdo Fraser MSP ...
- Coronavirus Cure: After FabiFlu, DGCI approves Covifor and Cipremi for COVID-19 treatment | All you need to knowon June 22, 2020 at 12:57 am
The DGCI has allowed Cipla and Hetero Labs to launch generic versions of Remdesivir under the brand names Cipremi and Covifor respectively ...
- Coronavirus Cure: DGCI approves Glenmark to manufacture Favipiravir for COVID-19 treatment; here’s all you need to knowon June 21, 2020 at 2:33 am
The domestic pharma giant announced the launch of the first oral Favipiravir in the brand name FabiFlu claiming that it is backed by strong clinical evidence showing encouraging results in patients wi ...
- Fighting Alzheimer’s disease: What are the causes, symptoms and treatment optionson June 20, 2020 at 12:13 pm
There is no cure for the disease. Although treatments can slow the progressive of the disease ... Many of the same activities you do for your heart also help keep your brain healthy. There is a strong ...
- Hormone therapy no cure-all for 'low T' in aging menon June 17, 2020 at 12:55 pm
Testosterone therapy ads promise to help aging men recapture their vitality, decrease body fat and enhance libido. But hormone treatments—while medically necessary for some men—aren't meant to be a ...